Keep a close eye on NFLD.
http://www.northfieldlabs.com/2020.htmlNorthfield Laboratories, a developer of hemoglobin-based oxygen-carrying red blood cell substitute, has submitted a biologics license application to the FDA for PolyHeme, the company's human hemoglobin-based red cell substitute for the treatment of life-threatening red blood cell loss when an oxygen-carrying fluid is required and red blood cells are not available.